Sugi Predict

Sugi Predict / Compounds / SCHEMBL1153592

SCHEMBL1153592

SCHEMBL1153592

CCC(O)(CC)[C@@H](CC(C)C)NC(=O)C1(C(=O)N[C@H](CC(C)C)C(O)(CC)CC)CCCC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 1/20 0.33
▸ PSEN1 P49768 2/20 0.32
▸ PSEN2 P49810 2/20 0.32
▸ APH1B Q8WW43 2/20 0.32
▸ NCSTN Q92542 2/20 0.32
▸ APH1A Q96BI3 2/20 0.32
▸ PSENEN Q9NZ42 2/20 0.32
▸ PSMB11 A5LHX3 1/20 0.31
▸ PSMA7 O14818 1/20 0.31
▸ PSMB1 P20618 1/20 0.31
▸ PSMA1 P25786 1/20 0.31
▸ PSMA2 P25787 1/20 0.31
▸ PSMA3 P25788 1/20 0.31
▸ PSMA4 P25789 1/20 0.31
▸ PSMB8 P28062 1/20 0.31
▸ PSMB9 P28065 1/20 0.31
▸ PSMA5 P28066 1/20 0.31
▸ PSMB4 P28070 1/20 0.31
▸ PSMB6 P28072 1/20 0.31
▸ PSMB5 P28074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1154204 0.98 MME (0.32) MMEPSEN1PSEN2APH1BNCSTN
SCHEMBL1154176 0.97 PSEN1 (0.34) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1153737 0.94 ALDH1A1 (0.30) ALDH1A1
SCHEMBL1153262 0.88 TSHR (0.31) MMEPSEN1PSEN2APH1BNCSTN
SCHEMBL1154254 0.87 TSHR (0.31) MMEPSEN1PSEN2APH1BNCSTN
SCHEMBL1153562 0.85 PSEN1 (0.33) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1153050 0.84 MME (0.34) MMEPSEN1PSEN2APH1BNCSTN
SCHEMBL1152986 0.83 MME (0.33) MMEPSEN1PSEN2APH1BNCSTN
SCHEMBL1154028 0.82 CYP3A4 (0.37) MME
SCHEMBL1153325 0.81 SPHK1 (0.31) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943799-B2 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-17 — — US disclosed
US-20110046415-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-24 — — US disclosed
US-7842839-B2 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-30 — — US disclosed
US-20070112201-A1 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-17 — — US disclosed
EP-1698617-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENE BISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF Sumitomo Chemical Company, Limited (JP) 2006-09-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112201-A1 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof CYP3A7, GRK7, CYP2A7 MME 4743/4885PSEN1 2926/4885PSEN2 3028/4885
US-20110046415-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF CYP3A7, GRK7, CYP2A7 MME 4743/4885PSEN1 2926/4885PSEN2 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.